StonvexLoading…
StonvexStonvexStonvexCore line items from NMAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $189.25M | $171.02M |
Operating Income | $-99.85M | $-69.81M |
Net Income | $-99.50M | $-72.17M |
EPS (Diluted) | $-0.96 | $-1.95 |
Total Assets | $239.84M | $146.07M |
Total Liabilities | $133.79M | $155.14M |
Cash & Equivalents | $20.43M | $24.05M |
Free Cash Flow OCF − CapEx | $-107.11M | $-49.68M |
Shares Outstanding | 108.21M | 41.07M |